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G-protein-coupled receptors (GPCRs)
constitute a large and diverse family of
proteins whose primary function is to
transduce extracellular stimuli into
intracellular signals. They are among the
largest and most diverse protein families
in mammalian genomes. On the basis of
homology with rhodopsin, they are
predicted to contain seven membrane-
spanning helices, an extracellular N-
terminus and an intracellular C-
terminus. This gives rise to their other
names, the 7-TM receptors or the
heptahelical receptors. GPCRs transduce
extracellular stimuli to give intracellular
signals through interaction of their
intracellular domains with
heterotrimeric G proteins, and the crystal
structure of one member of this group,
bovine rhodopsin, has recently been
solved (Palczewski et al., 2000).
The presence of GPCRs in the genomes
of bacteria, yeast, plants, nematodes and
other invertebrate groups argues in favor
of a relatively early evolutionary origin
of this group of molecules. The diversity
of GPCRs is dictated both by the
multiplicity of stimuli to which they
respond, as well as by the variety of
intracellular signalling pathways they
activate. These include light,
neurotransmitters, odorants, biogenic
amines, lipids, proteins, amino acids,
hormones, nucleotides, chemokines and,
undoubtedly, many others. In addition,
there are at least 18 different human Gα
proteins to which GPCRs can be coupled
(Hermans, 2003; Wong, 2003). These
Gα proteins form heterotrimeric
complexes with Gβ subunits, of which
there are at least 5 types, and Gγ
subunits, of which there are at least 11
types (Hermans, 2003). 
Estimates of the number of GPCRs in the
human genome vary widely. Based on
their sequences, as well as on their
known or suspected functions, there are
estimated to be five or six major classes
of GPCR. In a recent analysis of the
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GPCRs in the human genome, more than
800 GPCRs were listed (Fredriksson et
al., 2003). Of this total, 701 were in the
rhodopsin family (type A) and, of these,
241 were non-olfactory (Fredriksson et
al., 2003). According to this analysis,
there are approximately 460 type A
olfactory receptors, although estimates
range from 322 (Glusman et al., 2001;
Takeda et al., 2002) to 900 (Venter et al.,
2001), of which 347 have already been
cloned (Zozulya et al., 2001). This large
number of olfactory receptors accounts
for the ability of humans to detect a wide
variety of exogenous (olfactory) ligands.
A study similar to that of Fredriksson et
al. (Fredriksson et al., 2003) identified
367 human endoGPCRs and 392 mouse
endoGPCRs (Vassilatis et al., 2003); the
term endoGPCR refers to GPCRs for
endogenous (non-olfactory) ligands. In
view of the known existence of
alternatively spliced variants and editing
isoforms of GPCRs, it is likely that the
true number of GPCRs will never be
known and is much higher than
estimated.
The tree shown illustrates the
relationships among the primary protein
sequences of 274 type A rhodopsin-like
GPCRs; for clarity, the secretin family
receptors (of which there are 15), the
adhesion receptor family (24), the
glutamate receptor family (15) and the
frizzled/taste2 receptor family (24) were
not included. To construct this tree, the
list of receptors used by Fredriksson et
al. (Fredriksson et al., 2003) served as a
starting point, and newly discovered
‘orphan’ receptors were added to the list
(http://kidb.bioc.cwru.edu/rothlab/jalvie
w/viewJalView.html). 
The protein sequence of each receptor was
obtained, and the sequences of the N- and
C-termini, which are of variable length
and show little similarity among the
receptors, were trimmed manually. The
protein sequences were then aligned and
the tree was drawn using the ClustalW
server (http://clustalw.genome.ad.jp). An
alignment file is available at
http://kidb.bioc.cwru.edu/rothlab/jalview/
viewJalView.html and can be examined
with a more viewer-friendly interface
using the JalView applet at that site. The
G-protein-coupling information in the
poster is derived from the review by Wong
(Wong, 2003). 
The groupings of the receptors in the
poster are thus similar, but not identical,
to those of Fredriksson et al.
(Fredriksson et al., 2003). For example,
Fredriksson’s α, β, γ and δ groups,
which appear to be ‘monophyletic’ in
their tree, were not monophyletic in
ours; this is likely to be due to slight
differences in the options used in the two
alignments, and the relative imprecision
of the location of the roots of the
branches in both trees. Interestingly, the
orphan receptors GPR57 and GPR58
were grouped with the trace amine
receptors, and comparison of their
sequences indicates that these orphans
probably constitute the human
equivalent of the type 2 trace amine
receptors of rodents. Thus, trees of this
type may serve to help in the process of
‘de-orphanizing’ receptors.
How do GPCRs work?
The first step in signal transduction is
ligand binding. The nature of GPCR
ligand-binding sites is best studied by a
combination of site-directed
mutagenesis, molecular modelling of the
receptors and screening of large numbers
of potential ligands. Our group curates
the largest publicly accessible database
of ligand affinities as part of the
Psychoactive Drug Screening Program
(http://pdsp.cwru.edu), while the most
comprehensive database of the effects of
mutations in GPCRs upon ligand
binding can be found at http://www-
grap.fagmed.uit.no. Agonist binding is
followed by a change in the
conformation of the receptor that may
involve disruption of a strong ionic
interaction between the third and sixth
transmembrane helices (Ballesteros et
al., 2001; Shapiro et al., 2002), which
facilitates activation of the G-protein
heterotrimer. Depending on the type of
G protein to which the receptor is
coupled, a variety of downstream
signalling pathways can be activated
(reviewed by Marinissen and Gutkind,
2001; Neves et al., 2002). Signalling is
then attenuated (desensitized) by GPCR
internalization, which is facilitated by
arrestin binding (Ferguson, 2001).
Signalling, desensitization and eventual
resensitization are regulated by complex
interactions of various intracellular
domains of the GPCRs with numerous
intracellular proteins (Hall and
Lefkowitz, 2003; Bockaert et al., 2003).
Although many studies have used β-
adrenergic receptors as prototypical
GPCRs, it has become increasingly clear
that much more can be learned by
systematic study of other receptors. Our
studies of the serotonin 5-HT2A
receptor, for instance, showed that
GPCR internalization and
desensitization can occur by arrestin-
independent pathways (Bhatnagar et al.,
2001; Gray et al., 2003) and similar
findings have been reported for other
GPCRs (Lee et al., 1998). Interactions of
GPCRs with other proteins, including
cytoskeletal components such as PSD-95
(Hall and Lefkowitz, 2002; Xia et al.,
2003), are increasingly being found to be
important for regulating the activity,
targeting and trafficking of GPCRs.
GPCRs are attractive targets for
magic bullets
Although the biology of GPCRs is
certainly intriguing, their ultimate
importance is underscored by the fact
that at least one third (Robas et al., 2003)
and perhaps as many as half (Flower,
1999) of currently marketed drugs target
GPCRs, although only 10% of GPCRs
are known drug targets (Vassilatis et al.,
2003). As new functions for GPCRs are
discovered, especially for the orphan
GPCRs for which no function is
currently known, the number of drugs
that target GPCRs can only be expected
to increase. This is a focus of intense
research effort, both in academia and in
industry.
In addition to biological studies of the
types summarized above, much
excitement remains in the field because
of the continuing de-orphanization of
GPCRs and the subsequent elucidation
of their pharmacology and physiology. 
Once a large enough panel of GPCRs has
been obtained and comprehensively
characterized, a systematic analysis of
the ‘receptorome’ (the portion of the
proteome encoding receptors) can yield
important discoveries. We have used
such an approach to discover the
molecular mechanisms responsible for
serious drug side-effects – for example,
phen/fen-induced heart disease
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(Rothman et al., 2000) and weight gain
associated with the use of atypical
antipsychotics (Kroeze et al., 2003).
Additionally, screening the receptorome
has been used to elucidate the actions of
natural compounds and to obtain
validated molecular targets for drug
discovery (e.g. Roth et al., 2002).
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